New classes of potent and bioavailable human renin inhibitors
Remen, L., Bezencon, O., Richard-Bildstein, S., Bur, D., Prade, L., Corminboeuf, O., Boss, C., Grisostomi, C., Sifferlen, T., Strickner, P., Hess, P., Delahaye, S., Treiber, A., Weller, T., Binkert, C., Steiner, B., Fischli, W.(2009) Bioorg Med Chem Lett 19: 6762-6765
- PubMed: 19853442 
- DOI: https://doi.org/10.1016/j.bmcl.2009.09.104
- Primary Citation of Related Structures:  
3K1W - PubMed Abstract: 
New classes of de novo designed renin inhibitors are reported. Some of these compounds display excellent in vitro and in vivo activities toward human renin in a TGR model. The synthesis of these new types of mono- and bicyclic scaffolds are reported, and properties of selected compounds discussed.
Organizational Affiliation: 
Drug Discovery and Preclinical Research, Actelion Pharmaceuticals Ltd, CH-4123 Allschwil, Switzerland.